methotrexate has been researched along with Menopause, Premature in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (42.86) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 3 (42.86) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Camarata, M; Cooke, R; Dancy, G; Krell, J; Kwan, A; O'Nions, J; Savage, P; Seckl, MJ; Short, D; Swerdlow, A | 1 |
Banas, T; Hajdyla-Banas, I; Juszczyk, G; Knafel, A; Ludwin, A; Ludwin, I; Niewegłowska, D; Pitynski, K | 1 |
Pritchard, KI | 1 |
Ataseven, B; Conrad, B; Eiermann, W; Graf, E; Hilfrich, J; Kaufmann, M; Loibl, S; Massinger-Biebl, H; Schumacher, M; Vescia, S; von Minckwitz, G | 1 |
Bagshawe, KD; Bower, M; Foskett, M; Holden, L; Newlands, ES; Rustin, GJ; Short, D | 1 |
Blau, R; Gazder, P; Lower, EE; Tummala, R | 1 |
Ennis, M; Goodwin, PJ; Hood, N; Pritchard, KI; Trudeau, M | 1 |
1 review(s) available for methotrexate and Menopause, Premature
Article | Year |
---|---|
Ovarian suppression/ablation in premenopausal ER-positive breast cancer patients. Issues and recommendations.
Topics: Adult; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Female; Fluorouracil; Gonadotropin-Releasing Hormone; Goserelin; Humans; Menopause, Premature; Methotrexate; Middle Aged; Ovariectomy; Ovary; Premenopause; Quality of Life; Receptors, Estrogen; Tamoxifen | 2009 |
1 trial(s) available for methotrexate and Menopause, Premature
Article | Year |
---|---|
Dose-intensified epirubicin versus standard-dose epirubicin/cyclophosphamide followed by CMF in breast cancer patients with 10 or more positive lymph nodes: results of a randomised trial (GABG-IV E-93) - the German Adjuvant Breast Cancer Group.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Administration Schedule; Epidemiologic Methods; Epirubicin; Female; Fluorouracil; Humans; Lymphatic Metastasis; Menopause, Premature; Methotrexate; Middle Aged; Prognosis; Receptors, Estrogen; Receptors, Progesterone; Treatment Outcome | 2010 |
5 other study(ies) available for methotrexate and Menopause, Premature
Article | Year |
---|---|
Effects of single-agent and combination chemotherapy for gestational trophoblastic tumors on risks of second malignancy and early menopause.
Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Cohort Studies; Cyclophosphamide; Dactinomycin; Etoposide; Female; Follow-Up Studies; Gestational Trophoblastic Disease; Humans; Incidence; Kaplan-Meier Estimate; Menopause, Premature; Methotrexate; Middle Aged; Neoplasms, Second Primary; Odds Ratio; Pregnancy; Risk Assessment; Risk Factors; Uterine Neoplasms; Vincristine; Young Adult | 2015 |
Age at natural menopause in women on long-term methotrexate therapy for rheumatoid arthritis.
Topics: Adult; Age Factors; Arthritis, Rheumatoid; Case-Control Studies; Female; Humans; Immunosuppressive Agents; Menopause, Premature; Methotrexate; Middle Aged | 2016 |
Chemotherapy for gestational trophoblastic tumours hastens menopause by 3 years.
Topics: Adult; Antineoplastic Agents; Choriocarcinoma; Dactinomycin; Etoposide; Female; Follow-Up Studies; Humans; Hydroxyurea; Leucovorin; Menopause, Premature; Mercaptopurine; Methotrexate; Middle Aged; Pregnancy; Retrospective Studies; Risk Factors; Trophoblastic Neoplasms | 1998 |
The risk of premature menopause induced by chemotherapy for early breast cancer.
Topics: Adult; Amenorrhea; Antibiotics, Antineoplastic; Antineoplastic Agents; Breast Neoplasms; Estradiol; Female; Follicle Stimulating Hormone; Follow-Up Studies; Humans; Menopause, Premature; Methotrexate; Primary Ovarian Insufficiency; Retrospective Studies; Risk Factors; Time Factors | 1999 |
Risk of menopause during the first year after breast cancer diagnosis.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Cytarabine; Epirubicin; Female; Fluorouracil; Humans; Mastectomy; Menopause, Premature; Methotrexate; Middle Aged; Multivariate Analysis; Premenopause; Probability; Risk Factors; Tamoxifen | 1999 |